Berenberg addresses the stock's 7% year-to-date decline, attributing it primarily to Middle East exposure amid heightened regional tensions. This situation has prompted a downward revision of forecasts, with an estimated impact of 40 million euros and a 3% reduction in 2026 EBITDA.

According to the broker, Accor's exposure—representing 8% of rooms and approximately 10% of revenue—makes it particularly sensitive, with a projected 60-70% RevPAR shock in the United Arab Emirates. However, profit protection measures are expected to partially mitigate these effects.

The note also highlights the disposal of the stake in Ennismore, which could reach 975 million euros, providing support for share buybacks. Finally, valuation remains attractive in the analyst's view, with the stock trading at a discount relative to its peers.